LXEO
Lexeo Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$6.66
+0.03 ▲ +0.45%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$6.66
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -2.7 | Insider Own | 15.91% | Shs Outstand | 0.07B | Perf Week | -2.77% |
| Market Cap | 0.49B | Forward P/E | - | EPS next Y | 21.84% | Insider Trans | -0.37% | Shs Float | 0.06B | Perf Month | -1.91% |
| Enterprise Value | 0.37B | PEG | - | EPS next Q | -0.31 | Inst Own | 99.57% | Short Float | 18.13% | Perf Quarter | -31.55% |
| Income | -0.10B | P/S | - | EPS this Y | 37.04% | Inst Trans | 29.98% | Short Ratio | 9.44 | Perf Half Y | 28.57% |
| Sales | 0.00B | P/B | 3.03 | EPS next 5Y | 24.04% | ROA | -66.08% | Short Interest | 11.13M | Perf YTD | -32.93% |
| Book/sh | 2.2 | P/C | 3.96 | EPS past 3/5Y | -17.65% -99.98% | ROE | -80.69% | 52W High | -39.4% ($10.99) | Perf Year | 124.24% |
| Cash/sh | 1.68 | P/FCF | - | Sales past 3/5Y | - | ROIC | -82.93% | 52W Low | 359.31% ($1.45) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 4.97% | Gross Margin | - | Volatility(W/M) | 9.69% 7.51% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.55 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 7.4 | EPS Q/Q | 62.71% | Profit Margin | - | RSI (14) | 43.16 | Recom | 1.09 |
| Dividend Gr. 3/5Y | - | Current Ratio | 7.4 | Sales Q/Q | - | SMA20 | -1.54% ($6.76) | Beta | 1.8 | Target Price | $19.64 |
| Payout | - | Debt/Eq | 0.07 | Earnings | 11000000 | SMA50 | -10.77% ($7.46) | Rel Volume | 1.51 | Prev Close | $6.63 |
| Employees | 72 | LT Debt/Eq | 0.05 | EPS/Sales Surpr. | 36.54% - | SMA200 | -0.82% ($6.72) | Avg Volume(3M) | 1.18M | Price | $6.66 |
| IPO | 2023/11/3 | Option/Short | Yes/Yes | Trades | 10329 | Volume | 1,777,759 | Change | 0.45% |
뉴스 로딩 중...